Press Release / Jan 16, 2025
Hovione strengthens its global position as a top employer for the third consecutive year
Hovione has once again solidified its position as a top employer.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione has once again solidified its position as a top employer.
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Commitment to partnership and joint innovation for cell and gene therapies
Outsourced Pharma, April 2023
Hovione commitment to setting SBTs in line with the Paris Agreement
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction